Abbott (NYSE:ABT) announced that it made its Lingo continuous glucose monitoring (CGM) system available for purchase on ...
Tandem Diabetes Care announced that the FDA cleared its Control-IQ+ automated insulin delivery algorithm for people with type ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results